Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 2 Lymphoid 1 Genitourinary 1 Classical hematology 1

Conditions

Urinary Bladder Neoplasms 1

Interventions

Surveys and Questionnaires 52 Blood Specimen Collection 47 enzalutamide 29 radium Ra 223 dichloride 22 Biopsy 20 darolutamide 19 Radiotherapy 19 Docetaxel 19 apalutamide 18 Sunitinib 18 Magnetic Resonance Spectroscopy 18 Sorafenib 17 Abiraterone Acetate 17 Watchful Waiting 16 Interviews as Topic 15 Gene Expression Profiling 15 Amplified Fragment Length Polymorphism Analysis 15 Observation 13 Leuprolide 13 Immunohistochemistry 13 Androgen Antagonists 13 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 12 Magnetic Resonance Imaging 12 avelumab 11 Specimen Handling 11 abiraterone 9 Polymerase Chain Reaction 9 Flow Cytometry 9 Radiosurgery 8 Microarray Analysis 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Blood Transfusion × Genitourinary × Clear all

NCT04537221 2020-11-25

NorCys-Transf

Turku University Hospital

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡